Cargando…
Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease
Promoting remyelination following injury to the central nervous system (CNS) promises to be an effective neuroprotective strategy to limit the loss of surviving axons and prevent disability. Studies confirm that multiple sclerosis (MS) and spinal cord injury lesions contain myelinating cells and the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120407/ https://www.ncbi.nlm.nih.gov/pubmed/18219820 http://dx.doi.org/10.1007/978-3-540-73677-6_9 |